ARIAD is engaged in the discovery and development of breakthrough medicines to treat cancer by regulating cell signaling with small molecules. ARIAD is developing a comprehensive approach to patients with cancer that addresses the greatest medical need - aggressive and advanced-stage cancers for which current treatments are inadequate. ARIAD has a global partnership with Merck & Co., Inc. to develop and commercialize deforolimus, ARIAD's lead cancer product candidate. As a result of this partnership with Merck, which was announced in July 2007, ARIAD received an up-front investment of $75 million which was rapidly followed by a $13.5 million milestone payment for the launch of the phase 3 trial in September 2007. Medinol Ltd. also is developing stents and other medical devices that deliver deforolimus to prevent reblockage at sites of vascular injury following stent-assisted angioplasty. ARIAD has an exclusive license to pioneering technology and patents related to certain NF-(kappa)B treatment methods, and the discovery and development of drugs to regulate NF-(kappa)B cell-signaling activity, which may be useful in treating certain diseases.
Additional information about ARIAD can be found on the web at http://www.ariad.com.
Pathways to Success
ARIAD's success depends on talented and experienced people who are dedicated to driving success in developing better cancer therapies. If you welcome challenge and thrive on opportunity, we strongly encourage you to consider a career at ARIAD.
Mission & Vision
ARIAD’s mission is to provide cancer patients with significantly better treatment options. Based on our expertise in the regulation of cell signaling, we are developing and commercializing breakthrough therapies for a broad range of cancers. The success of our development programs is moving us closer to realizing our vision of becoming a fully integrated oncology company addressing unmet needs with new molecularly targeted therapies and improving the lives of cancer patients throughout the world.
Values
• Teamwork: The atmosphere at ARIAD is one of collaboration and support. Effective teamwork requires close cooperation and a willingness to listen.
• An Entrepreneurial Spirit: At ARIAD, we value the contribution of dedicated individuals who have ambition, a need to create, and a willingness to take calculated risks.
• Excellence: We provide unique opportunities for motivated people who value personal and professional growth and want to achieve their full potential.
• Creativity: Ours is a fast-moving business where success demands fresh thinking and creative problem solving.
• Mutual respect: Through an atmosphere of mutual respect, we create an environment that nurtures confidence and trust.
Last Updated: 12-19-2007